Over the past 12 months, $CNTA generated 6 mentions from 2 distinct FinTwit voices, with biotech-focused commentary dominating discussion. @adamfeuerstein led with 4 mentions, while @ssi_invest contributed 3 mentions. The ticker first appeared in the archive on 2026-03-31 and most recently on 2026-04-27. The acquisition by Eli Lilly was announced with a structure of $38.00 per share in cash plus up to $9.00 in contingent value rights tied to FDA milestones for ORX750 and ORX142, with the CVR initially valued at approximately $1.72. Regulatory risk was characterized as minimal, though shareholder approval remained required.